CLOMIPHENE CITRATE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Directrx. The primary component is Clomiphene Citrate.
| Product ID | 61919-375_8385b73e-08c4-d697-e053-2a91aa0a9f8f |
| NDC | 61919-375 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CLOMIPHENE CITRATE |
| Generic Name | Clomiphene Citrate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-03-04 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA075528 |
| Labeler Name | DIRECTRX |
| Substance Name | CLOMIPHENE CITRATE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Selective Estrogen Receptor Modulators [MoA],Estrogen Agonist/Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-03-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA075528 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-03-04 |
| Ingredient | Strength |
|---|---|
| CLOMIPHENE CITRATE | 50 mg/1 |
| SPL SET ID: | 834802c8-911f-55e7-e053-2a91aa0a5c7d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 21695-114 | Clomiphene Citrate | Clomiphene Citrate |
| 49884-701 | Clomiphene Citrate | Clomiphene Citrate |
| 50090-0677 | Clomiphene Citrate | Clomiphene Citrate |
| 50090-0678 | Clomiphene Citrate | Clomiphene Citrate |
| 61919-375 | CLOMIPHENE CITRATE | CLOMIPHENE CITRATE |
| 63629-2165 | Clomiphene Citrate | Clomiphene Citrate |
| 63629-5302 | Clomiphene Citrate | Clomiphene Citrate |
| 63629-9276 | Clomiphene Citrate | Clomiphene Citrate |
| 68071-2166 | Clomiphene Citrate | Clomiphene Citrate |
| 68071-2638 | Clomiphene Citrate | Clomiphene Citrate |
| 68071-4676 | Clomiphene Citrate | Clomiphene Citrate |
| 0713-0885 | Clomid | Clomiphene Citrate |